Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program

ASEM 文献综述

Official National Advisory Committee on Immunization document (2024) on “Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program”. Valid as of May 24, 2024: Summary of the National Advisory Committee on Immunization's interim guidance on the use of Imvamune in the context of a routine immunization program.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。